Boer Daniel Anton De
Chief Executive Officer at ProQR Therapeutics N.V.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 6 months
- Director since
- 2026
6 months of board service in total across 1 board, counting each seat separately. Longest: ProQR Therapeutics N.V., 6 months.
ProQR Therapeutics N.V.
Director · Chief Executive Officer
Chief executive roles
ProQR Therapeutics N.V.
· Chief Executive Officer
Since March 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | ProQR Therapeutics N.V. | Open-market purchase | +200,000 | $1.77 | $353,960 |
| Jul 9, 2026 | ProQR Therapeutics N.V. | Open-market purchase | +150,000 | $1.74 | $261,000 |
| Jul 7, 2026 | ProQR Therapeutics N.V. | Open-market purchase | +150,000 | $1.59 | $238,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.